- Home
- PESI vs BIOA Comparison
PESI vs BIOA Comparison
Compare PESI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- BIOA
- Stock Information
- Founded
- PESI 1990
- BIOA 2015
- Country
- PESI United States
- BIOA United States
- Employees
- PESI N/A
- BIOA N/A
- Industry
- PESI Environmental Services
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- PESI Industrials
- BIOA Health Care
- Exchange
- PESI Nasdaq
- BIOA Nasdaq
- Market Cap
- PESI 205.4M
- BIOA 175.7M
- IPO Year
- PESI 1992
- BIOA 2024
- Fundamental
- Price
- PESI $12.91
- BIOA $7.24
- Analyst Decision
- PESI
- BIOA Hold
- Analyst Count
- PESI 0
- BIOA 4
- Target Price
- PESI N/A
- BIOA $9.00
- AVG Volume (30 Days)
- PESI 214.5K
- BIOA 663.2K
- Earning Date
- PESI 11-10-2025
- BIOA 11-06-2025
- Dividend Yield
- PESI N/A
- BIOA N/A
- EPS Growth
- PESI N/A
- BIOA N/A
- EPS
- PESI N/A
- BIOA N/A
- Revenue
- PESI $60,019,000.00
- BIOA $3,863,000.00
- Revenue This Year
- PESI $8.35
- BIOA N/A
- Revenue Next Year
- PESI $82.81
- BIOA N/A
- P/E Ratio
- PESI N/A
- BIOA N/A
- Revenue Growth
- PESI N/A
- BIOA N/A
- 52 Week Low
- PESI $6.25
- BIOA $2.88
- 52 Week High
- PESI $15.75
- BIOA $23.72
- Technical
- Relative Strength Index (RSI)
- PESI 53.89
- BIOA 60.17
- Support Level
- PESI $12.60
- BIOA $7.09
- Resistance Level
- PESI $13.43
- BIOA $7.88
- Average True Range (ATR)
- PESI 0.71
- BIOA 0.50
- MACD
- PESI -0.17
- BIOA -0.01
- Stochastic Oscillator
- PESI 22.32
- BIOA 59.28
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.